Physician profile
David S Ross
NPI 1811951684
$667.15
in general payments reported to CMS, 2019-2025
9 companies · $315 in 2025
The $315 reported for 2025 was more than what 89% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.43 · 2022: $43.52 · 2023: $128 · 2024: $164 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.22 |
| Education | $164.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $345.09 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Daiichi Sankyo INC. | $86.80 | 2023-2024 | Vanflyta, Enhertu, Injectafer |
| Lilly USA, LLC | $71.62 | 2021-2024 | Retevmo, Jaypirca, Verzenio |
| Janssen Pharmaceuticals, INC | $43.52 | 2022 | |
| Boston Scientific Corporation | $30.99 | 2025 | Rhythmia Mapping System |
| Alnylam Pharmaceuticals INC. | $23.89 | 2023 | Givlaari |
| Abbvie INC. | $23.53 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.39 | 2025 | |
| Eisai INC. | $18.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.